Popular Content
Featured Articles

View Full Article

Current Perspectives on Multiple Sclerosis 1/20/2016

MS manifests as neurologic signs and symptoms related to declining neuromuscular, sensory, and cognitive function, with a waxing and waning pattern of symptoms and/or continuous disease progression.
View Full Article

Early Management of Acute Ischemic Stroke: Focus on IV tPA and Timely Reperfusion 1/20/2016

Recently updated guidelines have expanded the time window eligibility for treatment.

View Full Article

Medical Cannabis: Pharmacy Focus on Treatment Options for Neurologic Conditions 1/20/2016

There is increasing evidence for the efficacy and safety of medical marijuana.

View Full Article

Muscular Dystrophy: Options for Complication Management 1/20/2016

There are nine clearly defined types of muscular dystrophy, each differing in age of onset, clinical symptomology, muscle groups impacted, and associated complications.
View Full Article

Narcolepsy: Evolutions in Pharmacotherapy 1/20/2016

Narcolepsy is a complex and often debilitating neurologic disease characterized by excessive daytime sleepiness, uncontrollable sleep attacks, hypnagogic (drowsiness preceding sleep) and hypnopompic (semiconsciousness preceding waking) hallucinations, and sleep paralysis.
View Full Article

Optic Neuritis: A Brief Review 1/20/2016

Based upon disease etiology, this inflammatory condition is classified as typical or atypical.

Drug-Induced Bleeding 12/14/2015

Drug-induced bleeding presents in many ways, including excessive bruising, nosebleeds, heavy menses, gastrointestinal bleeding, and rectal bleeding.

Gastroesophageal Reflux Disease Management in Pediatric Patients 12/14/2015

It is important to distinguish simple reflux from GERD in order to avoid unnecessary diagnostics and therapies.

Overuse of Proton Pump Inhibitors in the Hospitalized Patient 12/14/2015

Overutilization of PPIs has led to higher hospital-related costs and more adverse effects.

Pain Management Considerations in Cirrhosis 12/14/2015

Practitioners must consider the increased potential for drug-induced liver injury in patients with preexisting liver disease.

The Pharmacologic Management of Motion Sickness 12/14/2015

Motion sickness is a common malady in the general population; however, the exact mechanism through which it occurs is not completely known.

Utility of Probiotics in Gastrointestinal Disease 12/14/2015

Patients may need help in understanding the key differences between the many available OTC formulations.

Coexistent Mental Health Disorders in Diabetic Patients 11/16/2015

Diabetic patients may be particularly vulnerable to developing mental health disorders because diabetes is considered one of the most psychologically and behaviorally demanding chronic medical conditions.

Cognitive Impairment During Hospitalization: The Pharmacist’s Role in Monitoring 11/16/2015

There are many reasons for the occurrence of cognitive impairment in patients during hospitalization, and this impairment can have a long-term impact post discharge.

Controlling Symptoms of Borderline Personality Disorder 11/16/2015

A pattern of impulsiveness and mood instability characterizes this psychological condition.

Managing Neuropsychiatric Symptoms in Traumatic Brain Injury 11/16/2015

Patients should be monitored for increased intracranial pressure and seizure occurrence.

Managing Posttraumatic Stress Disorder in an Outpatient Setting 11/16/2015

Posttraumatic stress disorder is a mental health condition that is triggered by experiencing or witnessing a traumatic event involving the possibility of serious injury or death.

Pharmacologic Management of Acute and Chronic Panic Disorder 11/16/2015

Differential diagnosis of a panic attack is critical to providing appropriate drug therapy.

QTc Prolongation With Antidepressants and Antipsychotics 11/16/2015

QT-interval prolongation is estimated to occur in up to 10% of patients taking antiarrhythmic drugs with QT-prolonging potential.

Advances in the Pharmacotherapy of Hereditary Angioedema 10/16/2015

New therapies prevent and reduce the duration and severity of swelling episodes.

For more articles, please check our archives.